Get started
Author

Rahime Şahin

The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer
2024 · Ediz Beyhan, Tevfik Fikret Çermik, et al. · Clinical Nuclear Medicine · 19
Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging: Complementary Role in PSMA-Negative Cases
2024 · Nurhan Ergül, Tevfik Fikret Çermik, et al. · Clinical Nuclear Medicine · 18
The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings
2023 · Esra Arslan, Nurhan Ergül, et al. · Nuclear Medicine Communications · 15
The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions
2023 · Özge Erol Fenercioğlu, Ediz Beyhan, et al. · Nuclear Medicine Communications · 8
A Comparison of 18F-FDG PET/CT and 68Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer
2023 · Ahmet Ertuğrul Öztürk, Rahime Şahin, et al. · Clinical Nuclear Medicine · 7
Findings of I-131 SPECT/CT, 18F-FDG, and 68Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma
2023 · Gamze Tatar, Göksel Alçın, et al. · Molecular Imaging and Radionuclide Therapy · 7
PDF
Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung
2021 · Esra Arslan, Özge Erol, et al. · Clinical Nuclear Medicine · 5
68Ga-DOTA-FAPI-46 PET/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma
2024 · Rahime Şahin, Mehmet Can Baloğlu, et al. · Clinical Nuclear Medicine · 4
Dual 177Lu–Prostate-Specific Membrane Antigen and 177Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation
2024 · Ediz Beyhan, Özge Erol Fenercioğlu, et al. · Clinical Nuclear Medicine · 4
18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor
2022 · Rahime Şahin, Sevim Baykal Koca, et al. · Clinical Nuclear Medicine · 4
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?
2025 · Esra Arslan, Nurhan Ergül, et al. · Cancers · 2
PDF
68Ga-NODAGA–Exendin-4 PET/CT Findings in a Case of Metastatic Insulinoma With Refractory Hypoglycemia Controlled by 90Y Transarterial Radioembolization
2024 · Rahime Şahin, İbrahim Taşkın Rakıcı, et al. · Clinical Nuclear Medicine · 2
Two Cases of Acrometastasis from Lung Cancer Revealed on 18F-FDG PET/CT
2022 · Rahime Şahin, Özge Erol Fenercioğlu, et al. · Molecular Imaging and Radionuclide Therapy · 2
PDF
Diagnostic Performance of 68Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions
2026 · Ömer F. Şahin, Zehranur Tosunoğlu, et al. · Clinical Nuclear Medicine · 1
Increased FDG Uptake in Skin Rashes Caused by EGFR Inhibitors
2022 · Özge Erol Fenercioğlu, Merve Cin, et al. · Clinical Nuclear Medicine · 1
Clinical Value of 68Ga-DOTA-Bombesin PET/CT Compared With 18F-FDG PET/CT in the Staging of Breast Cancer
2026 · Mehmet Can Baloglu, Rahime Şahin, et al. · Clinical Nuclear Medicine
Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on 18F-FDG PET/CT
2023 · Ömer Faruk Şahin, Rahime Şahin, et al. · Molecular Imaging and Radionuclide Therapy
PDF
Multiple Subcutaneous 18F-FDG-avid Granulomas Due to Enoxaparin Injection
2022 · Özge Erol Fenercioğlu, Nurhan Ergül, et al. · Molecular Imaging and Radionuclide Therapy
PDF
68Ga-DOTATATE Uptake in Well-Differentiated Neuroendocrine Tumor of the External Auditory Canal
2022 · Özge Erol Fenercioğlu, Ediz Beyhan, et al. · Clinical Nuclear Medicine
Works count: 19
Citation count: 99
H-index: 6
I10-index: 3
Year
Topic
Type